論文 - 詳細
| RRC ID | 41753 |
|---|---|
| 著者 | Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S, Sugimachi K. |
| タイトル | Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. |
| ジャーナル | Int J Cancer |
| Abstract |
Remodeling of the chromatin template by inhibition of HDAC activities represents a potential transcriptional therapy for neoplastic disease. A number of HDAC inhibitors that modulate in vitro cell growth and differentiation have been developed. We analyzed the effects of TSA, a specific and potent HDAC inhibitor, on the human hepatoma cell lines HepG2 and Huh-7. TSA increased levels of acetylated histones H3 and H4 in both HepG2 and Huh-7. It inhibited cell proliferation in vitro and induced G(0)/G(1) arrest in HepG2 and apoptosis in Huh-7. Gene expression of liver-specific functions and liver-enriched transcription factors was upregulated by TSA. TSA upregulated the ammonia removal rate and the albumin synthesis rate of HepG2 and Huh-7. Our results indicate that TSA can induce cell-cycle arrest/apoptosis and hepatocyte differentiation in human liver cancer cell lines. |
| 巻・号 | 103(5) |
| ページ | 572-6 |
| 公開日 | 2003-2-20 |
| DOI | 10.1002/ijc.10699 |
| PMID | 12494463 |
| MeSH | Albumins / metabolism Ammonia / metabolism Apoptosis / drug effects* Carcinoma, Hepatocellular / enzymology Carcinoma, Hepatocellular / pathology* Cell Cycle / drug effects Cell Differentiation / drug effects Cell Division / drug effects Dose-Response Relationship, Drug Enzyme Inhibitors / pharmacology* Gene Expression Regulation, Neoplastic Hepatocytes / drug effects* Hepatocytes / metabolism Histone Deacetylase Inhibitors* Histones / metabolism Humans Hydroxamic Acids / pharmacology* Liver Neoplasms / enzymology Liver Neoplasms / pathology* Neoplasm Proteins / genetics Neoplasm Proteins / metabolism* Tumor Cells, Cultured / drug effects Tumor Cells, Cultured / enzymology Tumor Cells, Cultured / pathology |
| IF | 5.145 |
| 引用数 | 132 |
| WOS 分野 | ONCOLOGY |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 4 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | Hep G2 HuH-7(RCB1366) |